Navigation Links
Key Anthrax Virulence Factor Discovered
Date:1/24/2008

Bacterial nitric oxide protects pathogen from immune system attacks

THURSDAY, Jan. 24 (HealthDay News) -- Researchers have discovered how the anthrax bacterium protects itself from the immune system's biochemical assault.

The results reveal not only a novel aspect of anthrax virulence, they also suggest a new target, known as bacterial nitric oxide synthase (bNOS), for fighting the pathogen, said study leader Evgeny Nudler, a professor of biochemistry at the New York University School of Medicine.

"That is the obvious continuation of our work," said Nudler, "to find small molecule inhibitors of bacterial nitric oxide synthase that would not touch its human counterpart. If we are lucky, we will find this inhibitor that would potentially work as an antibiotic."

One expert thought the finding could have therapeutic potential.

"bNOS can definitely be a therapeutic target," said Philip Tierno Jr., director of clinical microbiology & immunology in the Departments of Microbiology & Pathology at New York University Medical Center. "Clearly they showed that it should be a target, and if that somehow could be met, they may have knocked out the virulence of the organism, as they showed in the mouse model."

"But it may be more complicated than the model suggests, and there may be more factors at play than they suggest," Tierno added. "Things may not be a simple as it seems, but it's certainly a step in the right direction and should be explored, and might offer a solution, especially because anthrax could be a viable candidate for a terrorist."

The results were reported in this week's issue of the Proceedings of the National Academy of Sciences.

According to Nudler, this study stems from earlier research in which his team determined that bNOS (an enzyme that synthesizes nitric oxide) protects some bacteria from the stress of oxidizing chemicals, including the hyd
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
2. Nasal Anthrax Vaccine Proves Effective in Animal Study
3. Key to MRSA Virulence in Community Discovered
4. Lupus in women: New genetic risk factors identified
5. Extended work hours should factor into return to job after injury
6. American Heart Association President Urges Congress to Support Preventative Measures to Reduce Risk Factors for the Nations No. 1 Killer
7. 5 Factors Help Predict Psychosis in Children
8. New insight into factors that drive muscle-building stem cells
9. Trichloroethylene is a risk factor for parkinsonism
10. Risk factors for Parkinsons disease under study
11. Pilot error declines as factor in airline mishaps
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Key Anthrax Virulence Factor Discovered
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... At the presentation of the 2015 ... discussion was focused on research presented by the Journal of Arthroplasty pertaining to ... – like driving. , Results of the study confirm what Santa Rosa Orthopaedics ...
(Date:7/30/2015)... ... 30, 2015 , ... World Breast-Feeding Week (Aug. 1-7) was ... have the nutrition required to grow into healthy adults. Medicationdiscountcard.com supports ... prescription pre-natal vitamins. , Folic Acid , Arguably one of the most important ...
(Date:7/29/2015)... Plano, TX (PRWEB) , ... July 30, 2015 ... ... best content available for their clients, BOC approved provider of online continuing ... six new course offerings to their exclusive Andrews Research and Education Sports Medicine ...
(Date:7/29/2015)... ... July 29, 2015 , ... Avatar Solutions has received official approval from ... Survey. , The CAHPS for PQRS Survey collects information about patients’ experiences ... eligible providers must participate or they will receive a 2% penalty in 2017. At ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, ... surrogacy journey from a treasured member of the CARE extended family. , By ... to help intended parents across the globe gain a newfound perspective on surrogacy in ...
Breaking Medicine News(10 mins):Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3
... Black Americans with lupus have a higher antibody response to ... This may be good news for black Americans with ... the flu vaccine were more likely to experience moderate to ... a greater response. As many as 322,000 adults in ...
... prevents and cures kidney failure in mice sheds light ... potential treatment in people with such illnesses. ... in animals," said study leader Marni J. Falk, M.D., ... at The Children,s Hospital of Philadelphia. "So these striking ...
... sperm quality and who are trying to have children should ... cell phone use appears to increase the level of testosterone ... sperm quality and a decrease in fertility. "Our ... postdoctoral fellow in the Department of Pharmacology and Toxicology and ...
... 19, 2011) The John Theurer Cancer Center at Hackensack ... Promise Foundation to host a skin cancer screening event on ... feature educational information on skin cancer prevention and offer free ... "Skin cancer can be a devastating disease, but ...
... Autnoma de Barcelona researchers have discovered that Viagra drastically ... disease. The research, published in Acta Neuropathologica , ... of the animals after eight days of treatment. Researchers ... out in patients given that the drug is well ...
... Today 16 countries announced new commitments to dramatically reduce ... Global Strategy for Women,s and Children,s Health. ... children,s health is reaching new and encouraging heights. The ... prove that saving the lives of the most vulnerable ...
Cached Medicine News:Health News:Black Americans With Lupus Have Better Response to Flu Vaccine 2Health News:Animal results may pave way to treating rare mitochondrial diseases in children 2Health News:Viagra could reduce multiple sclerosis symptoms 2Health News:New commitments to save women and children 2Health News:New commitments to save women and children 3Health News:New commitments to save women and children 4Health News:New commitments to save women and children 5Health News:New commitments to save women and children 6Health News:New commitments to save women and children 7Health News:New commitments to save women and children 8
(Date:7/29/2015)... DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2015. For the second quarter of 2015, the Company ... share, compared to a net loss of $13.4 million, or $0.18 ... six months ended June 30, 2015, the Company reported a net ... to net loss of $25.2 million, or $0.35 loss per share, ...
(Date:7/29/2015)... , July 29, 2015 Immune Pharmaceuticals Inc. ... secured financings of up to $21.5 million through two ... Inc. (NYSE: HTGC ) ("Hercules"), for a term loan ... mutual fund Discover Growth Fund ("Discover"), for the sale ... Preferred Stock ("Preferred Stock") for up to $12 million ...
(Date:7/29/2015)... DALLAS , July 29, 2015 ... Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), ... Appliances (Mandibular Advancement Device)], End User (Home Care Settings, ... by MarketsandMarkets, this report studies the global Sleep Apnea ... 2020. This market is expected to reach $5.3 Billion ...
Breaking Medicine Technology:Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7Sleep Apnea Devices Market Worth $5.3 Billion by 2020 2Sleep Apnea Devices Market Worth $5.3 Billion by 2020 3Sleep Apnea Devices Market Worth $5.3 Billion by 2020 4
... Phase I data from XL880, Phase II data from ... SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixis, Inc. ... investigational compounds XL880 and XL999 will be,presented at the ... is being held June 1 to 5 in Chicago,Illinois. ...
... many as,first-line in secondary stroke prevention , ... presented today at the,16th European Stroke Conference in ... dipyridamole plus ASA,is marketed as Aggrenox® or Asasantin® ... vascular events in patients who had,a TIA or ...
Cached Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
... of a 384 Well Plate at Once , ... plates, you need a pipettor that can adapt ... you get with our 16-channel Impact pipettor., Available ... innovation was specifically designed to allow you to ...
... and Alliance Catheter Delivery System ... introduction of catheters or devices ... a superior approach. These introducers ... peel-away introducer performance with a ...
The AXIUS™ Blower/Mister provides controlled delivery of CO2 and saline to improve visibility during anastomosis....
... System combines low-profile, high radial force, and excellent ... compatible stent system provides 6F sheath / 8F ... 10.0 mm). Now, with longer stents available, the ... lengths (28, 38, 56, 80 and 100 mm) ...
Medicine Products: